University of Virginia
Infectious Disease fellowship · Charlottesville, VA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Virginia's research in infectious disease, which the program shares with other departments and affiliated hospitals.
About University of Virginiainstitution-wide infectious disease research
Infectious Disease publications from University of Virginia and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
93
works per year
26th of 71 infectious disease fellowship programs
-11.2%
2-year growth
9th of 71 infectious disease fellowship programs
26.6%
in top 10% of field (works before 2025)
35th of 67 infectious disease fellowship programs
54.3%
cited above world average
22nd of 67 infectious disease fellowship programs
Works per year · * 2026 so far
Infectious Diseases · 444
Infectious Disease research topics at University of Virginia
Papers in the window; each links to the list on OpenAlex.
- SARS-CoV-2 and COVID-19 Research 72
- Tuberculosis Research and Epidemiology 70
- COVID-19 Clinical Research Studies 66
- Clostridium difficile and Clostridium perfringens research 65
- Viral gastroenteritis research and epidemiology 51
- HIV/AIDS Research and Interventions 39
- Infection Control in Healthcare 13
- SARS-CoV-2 detection and testing 11
Most cited at University of Virginia since 2024
All infectious disease papers there on OpenAlex
- Estimated global and regional causes of deaths from diarrhoea in children younger than 5 years during 2000–21: a systematic review and Bayesian multinomial analysisRobert E. Black et al. · The Lancet Global Health · 2024 · PubMed · cited 139
- Viral gastroenteritisThomas G. Flynn et al. · The Lancet · 2024 · PubMed · cited 67
- Macrophage peroxisomes guide alveolar regeneration and limit SARS-CoV-2 tissue sequelaeXiaoqin Wei et al. · Science · 2025 · PubMed · cited 58
- Insights from an N3C RECOVER EHR-based cohort study characterizing SARS-CoV-2 reinfections and Long COVIDEmily Hadley et al. · Communications Medicine · 2024 · PubMed · cited 56
- Wastewater-based epidemiology for COVID-19 surveillance and beyond: A surveyChen Chen et al. · Epidemics · 2024 · PubMed · cited 39
- A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacyShadisadat Esmaeili et al. · Nature Communications · 2024 · PubMed · cited 35
- National Hospitalization Rates and In-Hospital Mortality Rates of HIV–Related Opportunistic Infections in the United States, 2011–2018Catherine G. Bielick et al. · Clinical Infectious Diseases · 2024 · PubMed · cited 30
- Nutritionally acquired immunodeficiency must be addressed with the same urgency as HIV to end tuberculosisMadolyn Rose Dauphinais et al. · BMC Global and Public Health · 2024 · PubMed · cited 29
- Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccineIvan V. Kuzmin et al. · Nature Communications · 2024 · PubMed · cited 26
- How manufacturing won or lost the COVID-19 vaccine raceMichael L. King · Vaccine · 2024 · PubMed · cited 26